<DOC>
	<DOCNO>NCT00387881</DOCNO>
	<brief_summary>This study design determine efficacy tolerability TREXIMET ( formerly know TREXIMA ) compare placebo acute treatment probable migraine , sub-type migraine .</brief_summary>
	<brief_title>TREXIMET ( Formerly Known TREXIMA ) Acute Treatment Probable Migraine ( ICHD-II 1.6.1 )</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>At least 6 month history probably migraine ( 6 migraine attack per month ) Males woman childbearing potential adequate contraception . Physician diagnosis migraine ; history triptan ergot use ; history headache prophylaxis use Pregnant and/or nurse mother History cardiovascular disease . Uncontrolled hypertension . Basilar Hemiplegic migraine History stroke transient ischemic attack ( TIA ) . History epilepsy treat antiepileptic within past 5 year . Impaired hepatic renal function . History gastrointestinal bleeding ulceration . Allergy hypersensitivity Aspirin NSAID . Allergy hypersensitivity triptans . Participated investigational drug trial previous 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>sumatriptan succinate ,</keyword>
	<keyword>naproxen sodium ,</keyword>
	<keyword>parallel group ,</keyword>
	<keyword>double-blind ,</keyword>
	<keyword>placebo-controlled ,</keyword>
	<keyword>Combination product ,</keyword>
	<keyword>migrainous headache</keyword>
	<keyword>Probable migraine , sub-type Migraine</keyword>
	<keyword>probable migraine ,</keyword>
</DOC>